Navigation Links
Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2011
Date:4/26/2011

SAN DIEGO, April 26, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present a corporate overview at the following investment conferences during the month of May:

  • Deutsche Bank's 36th Annual Health Care Conference at the InterContinental Hotel in Boston on Tuesday, May 3, 2011 at 3:30pm Eastern Time (12:30pm Pacific Time)
  • Bank of America Merrill Lynch 2011 Health Care Conference at the Wynn Hotel in Las Vegas on Wednesday, May 11, 2011 at 4:40pm Eastern Time (1:40pm Pacific Time)
  • UBS Global Specialty Pharmaceuticals Conference 2011 at the UBS office in London on Tuesday, May 24, 2011 at 3:30am Eastern Time (12:30am Pacific Time).

  • Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com in the Investor Relations section.  A replay of each webcast will be available approximately three hours after the live webcast concludes and will remain available for 30 days.

    About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. For more information about Cadence, please visit www.cadencepharm.com. Contacts:

    William R. LaRue

    SVP, CFOCadence Pharmaceuticals, Inc.

    858-436-1400
    '/>"/>

    SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. Cadence, Inc. Expands Executive Team
    2. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
    3. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
    4. Cadence Pharmaceuticals to Present at Two Investment Conferences in February 2011
    5. AccessClosure Announces Launch of New Mynx Cadence™ Vascular Closure Device
    6. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
    7. Cadence Pharmaceuticals Reports Third Quarter 2010 Financial Results
    8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
    9. Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
    10. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
    11. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
    (Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
    (Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
    (Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
    (Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
    (Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
    Breaking Medicine News(10 mins):